Ceftriaxone Sodium Injection, Powder, For Solution
Product Images NDC 0409-7337

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ceftriaxone Sodium (NDC 0409-7337). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ceftriaxone Vial Hospira 01

FDA Label Image

Ceftriaxone Vial Hospira 02

FDA Label Image

Ceftriaxone Vial Hospira 03

Ceftriaxone Vial Hospira 03
This text contains information about a drug called "Ceftriaxone for Injection, USP". There are some technical details provided such as storage instructions and recommended use, but it is not clear enough to provide a useful description.*
FDA Label Image

Ceftriaxone Vial Hospira 04

FDA Label Image

Ceftriaxone Vial Hospira 05

Ceftriaxone Vial Hospira 05
This is a description of a product containing ceftriaxone sodium powder which can be dissolved in sterile water to form a solution for intravenous administration. Each vial contains 12 grams of ceftriaxone and should be reconstituted with 2 liters of suitable liquid for usual dosage. It is advised to store the solution at a controlled room temperature and protect from light. One milliliter of the solution provides approximately 350 mg of equivalent SO 2010 and 100 mg equivalent of ceftriaxone. This medication is sold in a package of 10 single-dose vials manufactured by Hospira.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.